stem cell biology

ChemRegen is a regenerative medicine research and development company located in San Diego, California, combining stem cell biology and drug development. Its initial technology is based on work done in collaboration between Dr. Mark Mercola of the Sanford Burnham Research Institute and Dr. John Cashman of the Human BioMolecular Research Institute, who also serves as Chief Operating Officer of ChemRegen. ChemRegen provides design, implementation, and interpretation of pre-clinical regenerative medicine drug development.

drug developmentpre-clinical drug developmentregenerative medicine research

Elixirgen Therapeutics develops life-changing therapies for rare diseases and aging-associated diseases using its ZSCAN4 and Bobcat® mRNA technologies. Its ZSCAN4 technology is in clinical trials to extend telomeres in patients with Telomere Biology Disorders, and its Bobcat® mRNA technology delivers large payloads such as full-length dystrophin for Duchenne muscular dystrophy.

autologous cell therapyclinical trialsmRNA design

Gameto is a biotechnology company focused on women's reproductive health, developing cell engineering solutions for infertility, IVF, egg freezing, and menopause. Its lead product, Fertilo, uses engineered ovarian support cells to enable egg maturation outside the body, aiming to make IVF and egg freezing shorter and easier. Fertilo is an investigational biologic in a U.S. Phase 3 clinical trial and is not FDA-approved for marketing in the US.

cell engineeringclinical trialsembryologyin vitro maturationiPSC-derived technology